RU93048868A - METHOD FOR SAFE INTRODUCTION OF FATTY ACIDS, ITS APPLICATION FOR THE TREATMENT OF CANCER, INFECTIOUS VIRAL DISEASES AND OTHER DISORDERS - Google Patents
METHOD FOR SAFE INTRODUCTION OF FATTY ACIDS, ITS APPLICATION FOR THE TREATMENT OF CANCER, INFECTIOUS VIRAL DISEASES AND OTHER DISORDERSInfo
- Publication number
- RU93048868A RU93048868A RU93048868/14A RU93048868A RU93048868A RU 93048868 A RU93048868 A RU 93048868A RU 93048868/14 A RU93048868/14 A RU 93048868/14A RU 93048868 A RU93048868 A RU 93048868A RU 93048868 A RU93048868 A RU 93048868A
- Authority
- RU
- Russia
- Prior art keywords
- fatty acids
- levels
- disorders
- viral diseases
- infectious viral
- Prior art date
Links
- 235000014113 dietary fatty acids Nutrition 0.000 title claims 9
- 239000000194 fatty acid Substances 0.000 title claims 9
- 150000004665 fatty acids Chemical class 0.000 title claims 9
- 208000001756 Virus Disease Diseases 0.000 title claims 2
- 201000011510 cancer Diseases 0.000 title claims 2
- 201000010099 disease Diseases 0.000 title claims 2
- 230000002458 infectious Effects 0.000 title claims 2
- 210000002381 Plasma Anatomy 0.000 claims 2
- 229910003002 lithium salt Inorganic materials 0.000 claims 2
- 159000000002 lithium salts Chemical class 0.000 claims 2
- 206010018910 Haemolysis Diseases 0.000 claims 1
- 230000002949 hemolytic Effects 0.000 claims 1
- 238000001990 intravenous administration Methods 0.000 claims 1
- WHXSMMKQMYFTQS-UHFFFAOYSA-N lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 claims 1
- 229910052744 lithium Inorganic materials 0.000 claims 1
Claims (1)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB9218064.5 | 1992-08-25 | ||
GB9218064,5 | 1992-08-25 | ||
GB929218064A GB9218064D0 (en) | 1992-08-25 | 1992-08-25 | Method for the safe intravenous administration of fatty acids |
GB9222654.7 | 1992-10-28 |
Publications (2)
Publication Number | Publication Date |
---|---|
RU93048868A true RU93048868A (en) | 1996-06-10 |
RU2112517C1 RU2112517C1 (en) | 1998-06-10 |
Family
ID=10720932
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
RU93048868A RU2112517C1 (en) | 1992-08-25 | 1993-08-24 | Method of safety fatty acids administration, its use for cancer treatment, infectious viral diseases |
Country Status (6)
Country | Link |
---|---|
US (1) | US5508307A (en) |
KR (1) | KR940003544A (en) |
GB (2) | GB9218064D0 (en) |
RU (1) | RU2112517C1 (en) |
TW (1) | TW325404B (en) |
ZA (1) | ZA936233B (en) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5773300A (en) * | 1995-05-18 | 1998-06-30 | Cell Therapeutics, Inc. | Neoplasia diagnostic method |
US6166076A (en) * | 1996-12-13 | 2000-12-26 | Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College | Taste enhancing food additives |
US7138431B1 (en) | 1998-02-23 | 2006-11-21 | Wake Forest University | Dietary control of arachidonic acid metabolism |
US6737078B1 (en) * | 1999-11-24 | 2004-05-18 | The Iams Company | Process for enhancing canine and feline reproductive performance |
US20050032897A1 (en) * | 2000-11-22 | 2005-02-10 | The Iams Company | Process for enhancing canine and feline reproductive performance |
JP5234450B2 (en) | 2007-09-21 | 2013-07-10 | 独立行政法人農業・食品産業技術総合研究機構 | Placenta stripping method using arachidonic acid derivatives, etc. |
US8343753B2 (en) * | 2007-11-01 | 2013-01-01 | Wake Forest University School Of Medicine | Compositions, methods, and kits for polyunsaturated fatty acids from microalgae |
EP2211881A4 (en) * | 2007-11-01 | 2012-01-04 | Wake Forest University School Of Medicine | Compositions and methods for prevention and treatment of mammalian diseases |
WO2016196894A1 (en) * | 2015-06-03 | 2016-12-08 | Kradl Therapeutics, Llc | Compositions of polyunsaturated fatty acids and methods of use thereof |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2040847T3 (en) * | 1987-04-27 | 1996-07-16 | Efamol Holdings | A PROCEDURE FOR PREPARING A PHARMACEUTICAL COMPOSITION CONTAINING A LITHIUM SALT. |
US5252333A (en) * | 1987-04-27 | 1993-10-12 | Scotia Holdings Plc | Lithium salt-containing pharmaceutical compositions |
JPH0386819A (en) * | 1989-04-27 | 1991-04-11 | Nippon Oil & Fats Co Ltd | Vascularization suppressing agent |
-
1992
- 1992-08-25 GB GB929218064A patent/GB9218064D0/en active Pending
- 1992-10-28 GB GB929222654A patent/GB9222654D0/en active Pending
-
1993
- 1993-08-24 RU RU93048868A patent/RU2112517C1/en active
- 1993-08-24 KR KR1019930016469A patent/KR940003544A/en not_active Application Discontinuation
- 1993-08-25 ZA ZA936233A patent/ZA936233B/en unknown
- 1993-08-25 TW TW082106876A patent/TW325404B/en active
-
1995
- 1995-01-26 US US08/378,708 patent/US5508307A/en not_active Expired - Fee Related
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2142314A1 (en) | Method of Reducing Blood Levels of Total Cholesterol and Low-Density Lipoprotein Cholesterol | |
GEP20002298B (en) | Benzimidazole Derivatives, Method of Their Production, Pharmaceutical Composition Containing the Same and Method for Its Treatment | |
KR930001902A (en) | Method for preparing fatty acid drug | |
KR950701350A (en) | METHOD AND COMPOSITIONS FOR THE TREATMENT OF DISEASES WITH INTERFERON WHILE REDUCING SIDE EFFECTS | |
ES2032382T3 (en) | METHOD FOR PREPARING A MEDICATION FOR THE PREVENTION OR TREATMENT OF ENDOMETRIOSIS. | |
RU93048868A (en) | METHOD FOR SAFE INTRODUCTION OF FATTY ACIDS, ITS APPLICATION FOR THE TREATMENT OF CANCER, INFECTIOUS VIRAL DISEASES AND OTHER DISORDERS | |
DE68926115D1 (en) | METHOD FOR TREATING ACNE | |
DE69424777D1 (en) | 3,4-DIARYLCHROMANE FOR TREATING DERMATITIS | |
TW325404B (en) | Pharmaceutical composition for the safe administration of fatty acids the invention relates to a pharmaceutical composition for the safe administration of fatty acids which is useful in the treatment of cancer, viral infections and other disorders. | |
IT1255968B (en) | PHARMACEUTICAL COMPOSITIONS CONTAINING URSODESOXICOLIC ACID | |
JPH072663A (en) | Virus infection remedy | |
Tavenner | Use of tranexamic acid in control of haemorrhage after extraction of teeth in haemophilia and Christmas disease | |
KR910005858A (en) | Fatty acid therapy | |
MX9301922A (en) | COMPOSITIONS FOR THE TREATMENT OF INFECTION AND DISEASE CAUSED BY THE VIRUS OF HEPATITIS B (HBV). | |
NO933016L (en) | Procedure for the safe administration of fatty acid | |
ATE92756T1 (en) | MEANS FOR TREATMENT OF KERATosis. | |
KR900701278A (en) | Bile acids for the treatment of viral infections | |
FR2707880B1 (en) | Pharmaceutical compositions and their use, in particular for the treatment of neurodegenerative diseases. | |
KR890009868A (en) | Trometamine salt of 1-methyl-β-oxo-α- (phenylcarbamoyl) -2-pyrrolepropionitrile | |
FR2561919B1 (en) | PHARMACEUTICAL COMPOSITION CONSTITUTED ON THE ONE HAND, AS ACTIVE INGREDIENT, BY 9A, 11B-DICHLORO 16A-METHYL 21-OXYCARBONYLDICYCLOHEXYL METHYLOXY PREGNA-1,4-DIENE 3,20-DIONE AND ON THE OTHER HAND, BY A PHARM EXCIPIENT INERTE CAPABLE OF ALLOWING THE ACTION OF THE PRODUCT IN THE RECTUM OR THE COLON | |
FR2616327B3 (en) | MIXTURE OF MEDICINAL PLANTS AS A MEDICAMENT FOR THE TREATMENT OF ULCERS AND CHRONIC GASTRITES | |
Miller et al. | Effect of penicillin dosage schedule on treatment of experimental typhoid infections in mice | |
SU1227005A1 (en) | Immunostimulator t-lymphocyte in treating neuroallergic disease | |
RU2071342C1 (en) | Method of treatment of cirrhotic form of lung tuberculosis | |
RU1822775C (en) | Method for treatment of trigeminal nerve neuralgia |